Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step

By sjmartinez • November 18, 2024

Khan S, Yancy CW, Fonarow GC. Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step. JAMA Cardiol. 2024 Nov 17. doi: 10.1001/jamacardio.2024.4624. Epub ahead of print. PMID: 39550719.

Tags: Cardiology/Epi, Publications

InChagas: Feasibility Study of a Tele-Education Strategy to Promote Early Identification and Care of People Living with Chagas Cardiomyopathy in an Endemic Community in Argentina

Gulayin PE, Gimenez C, Chirino D, Nascimento B, Salvá L, Cavallo AS, Gutierrez L, Blanco L, Flores LPC, Espina E, Shakil SS, Vervoort D, Davis[...]

Authors’ Perspective-Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update

Kobashigawa J, Zuckermann A, Potena L, Ardehali A, Berman M, Chang PP, Esmailian F, Farr M, Hall S, Hsich E, Khush K, Kittleson M, Leprince[...]

Protocol optimization for 18F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow

Ali FZ, Packard RRS. Protocol optimization for 18F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow. J Nucl Cardiol. 2026 Apr;58:102674. doi: 10.1016/j.nuclcard.2026.102674. PMID:[...]